Clinical Trial Update: Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating albuterol for dynamic hyperinflation in idiopathic pulmonary arterial hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Arterial Hypertension

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: American Medical Association Foundation | Conditions: Idiopathic Pulmonary Arterial Hypertension. | Phase 2 | Status: WITHDRAWN